ACTH-Secreting Pituitary Adenoma

Phase 3 trials (1)

• cabergoline

Organization Involved with Phase 4 Indications (2)

• Novartis
• University of Palermo

Organization Involved with Phase 3 Indications (6)

• Corcept Therapeutics
• Cortendo AB
• National Institutes of Health (NIH)
• University of London
• Seth Gordhandas Sunderdas Medical College
• Barts & The London NHS Trust

Organization Involved with Phase 2 Indications (9)

• AstraZeneca
• National Cancer Institute (NCI)
• National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
• National Institute of Neurological Disorders and Stroke (NINDS)
• Cedars-Sinai Medical Center
• University of Virginia
• Fudan University
• University of California, Los Angeles
• University of Oxford

Organization Involved with Other Experimental Indications (1)

• University of Lyon